Alpha Tau Medical Past Earnings Performance
Past criteria checks 0/6
Alpha Tau Medical's earnings have been declining at an average annual rate of -12.5%, while the Medical Equipment industry saw earnings growing at 12% annually.
Key information
-12.5%
Earnings growth rate
2.9%
EPS growth rate
Medical Equipment Industry Growth | 8.9% |
Revenue growth rate | n/a |
Return on equity | -42.7% |
Net Margin | n/a |
Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
No updates
Recent updates
Alpha Tau Medical (NASDAQ:DRTS) Has Debt But No Earnings; Should You Worry?
May 25Alpha Tau Medical (NASDAQ:DRTS) Is In A Good Position To Deliver On Growth Plans
Nov 08Alpha Tau director gives up board seat to take up chief commercial officer role
Sep 02Alpha Tau Medical GAAP EPS of -$0.03
Aug 25Alpha Tau: Treating Cancer With Precision Alpha Radiation
Apr 12Revenue & Expenses Breakdown
How Alpha Tau Medical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Sep 24 | 0 | -30 | 9 | 27 |
30 Jun 24 | 0 | -28 | 9 | 27 |
31 Mar 24 | 0 | -29 | 9 | 27 |
31 Dec 23 | 0 | -29 | 9 | 26 |
30 Sep 23 | 0 | -25 | 9 | 24 |
30 Jun 23 | 0 | -23 | 10 | 22 |
31 Mar 23 | 0 | -16 | 10 | 22 |
31 Dec 22 | 0 | -34 | 11 | 21 |
30 Sep 22 | 0 | -34 | 9 | 19 |
30 Jun 22 | 0 | -36 | 7 | 17 |
31 Mar 22 | 0 | -41 | 5 | 14 |
31 Dec 21 | 0 | -27 | 2 | 11 |
30 Sep 21 | 0 | -26 | 2 | 10 |
30 Jun 21 | 0 | -24 | 2 | 10 |
31 Mar 21 | 0 | -19 | 2 | 8 |
31 Dec 20 | 0 | -9 | 2 | 8 |
Quality Earnings: DRTS is currently unprofitable.
Growing Profit Margin: DRTS is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: DRTS is unprofitable, and losses have increased over the past 5 years at a rate of 12.5% per year.
Accelerating Growth: Unable to compare DRTS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: DRTS is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (10.4%).
Return on Equity
High ROE: DRTS has a negative Return on Equity (-42.71%), as it is currently unprofitable.